MedTrace Logo

Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis

NCT06139029 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-21

No results posted yet for this study

Summary

To compare the efficacy of 3% normal saline nebulization and steroid nebulization in the treatment of bronchiolitis in infants.

Conditions

  • Acute Bronchiolitis

Interventions

DRUG

3% normal saline

nebulization

DRUG

steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline

nebulization

Sponsors & Collaborators

  • Mardan Medical Complex

    lead OTHER

Principal Investigators

  • faizan sadiq, MBBS · Mardan Medical Complex

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-15
Primary Completion
2023-03-15
Completion
2023-03-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06139029 on ClinicalTrials.gov